Qin Xu - FDA Investigator Report

Overview Statistics

62
Total Inspections
21
Total 483s Issued
1
Warning Letters Issued

Inspection Details

Longest Inspection: 31 days
Shortest Inspection: 1 days
Average Length: 5.6 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Qin Xu's Recent Inspections

DateCompanyCityCountryFEI Number483
2019-09-16C-Care, LLCLinthicum HeightsUnited States3003071856
2019-06-14IntelliPharmaCeutics Corp.EtobicokeCanada3006370451
2019-06-07ANI Pharmaceuticals Canada, Inc.OakvilleCanada3002916530
2019-05-31Teva Canada LimitedStouffvilleCanada3002807750
2018-11-22OLIC (Thailand) LimitedBang Pa-InThailand3004039360
2018-11-16Colgate-Palmolive (Thailand) Limited - BranchAmphur MuangThailand3006803957
2018-11-09Formosa Laboratories, Inc.Taoyuan CityTaiwan3003420376
2018-10-04SigmaPharm Laboratories LLCBensalemUnited States3005444934
2018-08-17AstraZeneca Pharmaceuticals LPFrederickUnited States3002617771
2018-07-20Fareva Richmond, Inc.HenricoUnited States1120199

Sign Up to get the complete report.

Download 483s and EIRs for Qin Xu

Qin Xu - Co-Inspectors

Qin Xu's Active Locations

  • United States
  • China
  • Canada
  • India
  • Germany
  • Taiwan
  • Spain
  • Japan
  • Thailand

Qin Xu's Year-wise Inspection Count

  • 2014:1 inspections
  • 2015:18 inspections
  • 2016:19 inspections
  • 2017:9 inspections
  • 2018:11 inspections
  • 2019:4 inspections
Last Updated: 2025-05-14 06:11:22